US 7232890
AIB1, a novel steroid receptor co-activator
granted A61KA61K38/00A61P
Quick answer
US patent 7232890 (AIB1, a novel steroid receptor co-activator) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61P, A61P35/04